Osimertinib

Osimertinib is a targeted therapy medication used to treat non-small cell lung cancer (NSCLC). It is specifically indicated for patients with NSCLC that have a mutation in the epidermal growth factor receptor (EGFR) gene.

Uses: Osimertinib is primarily used to:

• Treat non-small cell lung cancer (NSCLC) with EGFR mutations
• Treat advanced or metastatic NSCLC

Important Considerations (Prescription Required):

1. EGFR Mutation: Osimertinib is only effective in patients with a specific mutation in the EGFR gene. Genetic testing is necessary to determine eligibility for treatment.
2. Severe Side Effects: Like other targeted therapies, Osimertinib can cause severe side effects, including skin rash, diarrhea, and liver problems. Regular monitoring is essential.
3. Prescription Only: Osimertinib is a prescription medication and should only be used under the guidance of a qualified medical professional.